China Steel Chemical Corp

China Steel Chemical Corp maintains a debt-to-equity ratio of 0.37, indicating a relatively conservative capital structure. However, the company's liquidity position is rated as medium, with only 17.98 million TWD in cash and equivalents, which is significantly lower than its long-term debt of 2.86 billion TWD. The current ratio of 1.83 suggests the company can cover its short-term liabilities, but the negative free cash flow of 531.75 million TWD highlights a cash outflow from operations after capital expenditures.

Profitability metrics show a return on equity of 7.88% and a return on assets of 5.38%, which are below the industry median for commodity chemicals. The operating margin of 9.15% (calculated from operating income of 535.84 million TWD on revenue of 5.86 billion TWD) is also below the industry average, indicating lower efficiency in converting revenue into profit.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue data limits the ability to assess the performance of different product lines or markets.

Looking ahead, the company is expected to see a modest increase in revenue, with a projected growth rate of 2.5% for the current fiscal year and 3.0% for the next fiscal year. These projections are based on historical revenue trends and industry demand forecasts. However, the company's capital expenditure of 528.73 million TWD suggests ongoing investment in infrastructure and production capacity.

The risk assessment indicates a medium liquidity risk due to the negative free cash flow and a low dilution risk. The company has not issued additional shares recently, and there are no indications of imminent dilution. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet long-term obligations without external financing.

Recent filings and transcripts do not highlight any major events or strategic shifts. The company's price targets from analysts are uniformly set at 100.00 TWD, with a mean recommendation of 2.25, indicating a generally positive outlook but with some caution. The lack of strong buy recommendations suggests a moderate level of confidence among analysts.